Explainable Artificial Intelligence for Drug Discovery & Development, 2018 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 27, 2018--The “Explainable Artificial Intelligence for Drug Discovery and Development” report has been added to ResearchAndMarkets.com’s offering.
This report encompasses recent advances in artificial intelligence platforms enabling drug discovery and development, while highlighting the importance of explainability in AI-driven technologies for healthcare. The report also provides an overview of the AI value chain.
Key Topics Covered
1. Recent Advances in Artificial Intelligence for Drug DiscoveryEmploying Artificial Intelligence for Drug Discovery Explainable Artificial Intelligence Solutions AI-based Drug Discovery Innovation Scouting Explainable AI Drug Discovery: Approaches and Features
2. Clinical Trial Analysis and Key ContactsKyndi’s Explainable AI Platform Key Contacts
For more information about this report visit https://www.researchandmarkets.com/research/37g9kg/explainable?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180927005362/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Drug Discovery
INDUSTRY KEYWORD: HEALTH OTHER HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/27/2018 05:51 AM/DISC: 09/27/2018 05:50 AM